NL-OMON28682招募中不适用
[68Ga]Ga-PentixaFor PET/CT imaging vs AVS in primary aldosteronism
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Radboudumc
- 入组人数
- 265
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •The patient has a diagnosis of primary aldosteronism, confirmed by an elevated aldosterone/rennin ratio (ARR) and an intravenous salt-loading test (according to the Endocrine Society guidelines)(1)
- •Age over 18 years at time of consent
- •Signed informed consent
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Refusal by the patients to undergo AVS, [68Ga]Ga-PentixaFor PET/CT, CT, or adrenalectomy
- •Suspicion of familial hyperaldosteronism type 1 (FH-1) or type 3 (FH-3)
- •Suspicion of adrenocortical carcinoma
- •Severe comorbidity potentially interfering with treatment or health-related quality of life
- •Requirement of medication interfering with the study protocol
- •Any medical condition present that in the opinion of the investigator will affect patients’ clinical status.
- •Pregnancy or lactation
- •Estimated glomerular filtration rate (eGFR) < 40 ml/min/1.73m²
研究者
相似试验
进行中（未招募）
1 期
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in primary aldosteronismMedDRA version: 20.1Level: PTClassification code: 10036692Term: Primary hyperaldosteronism Class: 100000004860Primary aldosteronismCTIS2024-512628-12-00Stichting Radboud universitair medisch centrum228
招募中
2 期
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in primary aldosteronismNL-OMON49887Radboud Universitair Medisch Centrum228
招募中
2/3 期
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS trial)Primary aldosteronism2024-512628-12-00Stichting Radboud universitair medisch centrum228
已完成
不适用
68Ga-PSMA-PET/CT imaging for locally advanced, recurrent and metastatic adenoid cystic carcinoma or salivary duct carcinomaAdenoid cystic carcinomaNL-OMON44299Radboud Universitair Medisch Centrum25
进行中（未招募）
1 期
PSMA-PET scan for incurable or metastatic salivary gland cancerEUCTR2017-002093-40-NLRadboudumc25